ATA435283A - Verfahren zur herstellung von neuen 7-carboxymethoxyphenyl-acetamido-3-cephemderivaten und deren pharmazeutisch akzeptablen salzen - Google Patents

Verfahren zur herstellung von neuen 7-carboxymethoxyphenyl-acetamido-3-cephemderivaten und deren pharmazeutisch akzeptablen salzen

Info

Publication number
ATA435283A
ATA435283A AT0435283A AT435283A ATA435283A AT A435283 A ATA435283 A AT A435283A AT 0435283 A AT0435283 A AT 0435283A AT 435283 A AT435283 A AT 435283A AT A435283 A ATA435283 A AT A435283A
Authority
AT
Austria
Prior art keywords
cephemde
carboxymethoxyphenyl
acetamido
pharmaceutical
derivatives
Prior art date
Application number
AT0435283A
Other languages
English (en)
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP21772682A external-priority patent/JPS59108791A/ja
Priority claimed from JP3601783A external-priority patent/JPS59161389A/ja
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of ATA435283A publication Critical patent/ATA435283A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
AT0435283A 1982-12-14 1983-12-14 Verfahren zur herstellung von neuen 7-carboxymethoxyphenyl-acetamido-3-cephemderivaten und deren pharmazeutisch akzeptablen salzen ATA435283A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21772682A JPS59108791A (ja) 1982-12-14 1982-12-14 ７−カルボキシメトキシフエニルアセトアミド−３−セフエム誘導体、その製造方法およびそれからなる抗菌剤
JP3601783A JPS59161389A (ja) 1983-03-07 1983-03-07 ７−カルボキシメトキシフエニルアセトアミドセフエム誘導体，その製造法およびそれからなる抗菌剤

Publications (1)

Publication Number Publication Date
ATA435283A true ATA435283A (de) 1986-12-15

Family

ID=26375029

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0435283A ATA435283A (de) 1982-12-14 1983-12-14 Verfahren zur herstellung von neuen 7-carboxymethoxyphenyl-acetamido-3-cephemderivaten und deren pharmazeutisch akzeptablen salzen

Country Status (16)

Country Link
US (1) US4546176A (de)
KR (1) KR840007012A (de)
AT (1) ATA435283A (de)
AU (1) AU2082783A (de)
BE (1) BE898442A (de)
CH (1) CH656131A5 (de)
DE (1) DE3345093A1 (de)
DK (1) DK572183A (de)
ES (2) ES8506025A1 (de)
FR (1) FR2569195B1 (de)
GB (1) GB2132613B (de)
IT (1) IT1169969B (de)
NL (1) NL8304272A (de)
PH (1) PH20168A (de)
SE (1) SE8306882L (de)
YU (1) YU237283A (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232918A (en) * 1987-07-23 1993-08-03 Imperial Chemical Industries Plc Cephalosporin derivatives
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
EP0997466A1 (de) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Antimikrobielle Laktamchinolone
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
US5273973A (en) * 1988-10-24 1993-12-28 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl esters
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
ES2147721T3 (es) * 1990-04-18 2000-10-01 Procter & Gamble Pharma Quinolonil lactamas antimicrobianas.
US5244892A (en) * 1990-10-16 1993-09-14 Kyorin Pharmaceutical Co., Ltd. Cephem compounds, and antibacterial agents
NZ290722A (en) * 1994-08-02 1999-03-29 Procter & Gamble A process for making derivatives of quinolonyl lactam (qla's); intermediates
JPH10504815A (ja) * 1994-08-02 1998-05-12 ザ、プロクター、エンド、ギャンブル、カンパニー 抗微生物化合物の製造方法
US7091196B2 (en) * 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
JP2006523229A (ja) * 2003-03-05 2006-10-12 リブ−エックス ファーマシューティカルズ，インコーポレイテッド 二官能性複素環式化合物ならびにその製造および使用方法
US20070149463A1 (en) * 2003-10-30 2007-06-28 Oyelere Adegboyega K Bifunctional macrolide heterocyclic compounds and methods of making and using the same
JP2007512256A (ja) * 2003-11-18 2007-05-17 リブ−エックス ファーマシューティカルズ，インコーポレイテッド 二官能性マクロライド複素環化合物ならびにこれらを製造する方法およびこれらを使用する方法
CN102816194A (zh) * 2004-02-27 2012-12-12 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR208171A1 (es) * 1972-09-29 1976-12-09 Ciba Geigy Ag Procedimiento para la obtencion de nuevos derivados del acido cef-3-em-4-carboxilico
US4338439A (en) * 1976-08-26 1982-07-06 Eli Lilly And Company 7-[2-[(Substituted benzoyl]amino]acetamido]cephalosporins
SE8009049L (sv) * 1980-03-04 1981-09-05 Eisai Co Ltd 7alfa-metoxicefalosporinderivat, sett for framstellning derav och antibakteriella lekemedel innehallande dessa foreningar
US4468394A (en) * 1981-04-02 1984-08-28 Eisai Co., Ltd. Cephalosporin compounds

Also Published As

Publication number Publication date
YU237283A (en) 1986-04-30
IT1169969B (it) 1987-06-03
DE3345093A1 (de) 1984-06-14
IT8324122A0 (it) 1983-12-12
NL8304272A (nl) 1984-07-02
ES8505691A1 (es) 1985-06-01
SE8306882L (sv) 1984-06-15
DK572183A (da) 1984-06-27
ES528003A0 (es) 1985-06-16
SE8306882D0 (sv) 1983-12-13
US4546176A (en) 1985-10-08
FR2569195A1 (fr) 1986-02-21
ES8506025A1 (es) 1985-06-16
PH20168A (en) 1986-10-09
GB2132613A (en) 1984-07-11
GB2132613B (en) 1986-05-08
KR840007012A (ko) 1984-12-04
CH656131A5 (de) 1986-06-13
ES534297A0 (es) 1985-06-01
AU2082783A (en) 1984-06-21
GB8329554D0 (en) 1983-12-07
DK572183D0 (da) 1983-12-13
BE898442A (fr) 1984-06-13
FR2569195B1 (fr) 1987-01-09

Similar Documents

Publication Publication Date Title
AT385506B (de) Verfahren zur herstellung von neuen carbostyrilderivaten und deren salzen
AT373880B (de) Verfahren zur herstellung von neuen imidazolderivaten und von deren salzen
AT381096B (de) Verfahren zur herstellung von neuen cephemverbindungen und deren pharmazeutisch unbedenklichen salzen
AT375646B (de) Verfahren zur herstellung von neuen sulfonamidopyridinderivaten und deren salzen
ATA435283A (de) Verfahren zur herstellung von neuen 7-carboxymethoxyphenyl-acetamido-3-cephemderivaten und deren pharmazeutisch akzeptablen salzen
AT374188B (de) Verfahren zur herstellung von neuen a-alkylimidazolderivaten und deren salzen
AT381705B (de) Verfahren zur herstellung von neuen thiazolidindion-derivaten und deren salzen
AT383592B (de) Verfahren zur herstellung von neuen carbostyrilderivaten und deren salzen
AT378188B (de) Verfahren zur herstellung von neuen thiazolidinderivaten und deren salzen
AT352137B (de) Verfahren zur herstellung von neuen piperazinylbenzopyron-derivaten und deren salzen
AT379804B (de) Verfahren zur herstellung von neuen phenaethylimidazolderivaten und von deren salzen
AT384810B (de) Verfahren zur herstellung von psoralenfreien neuen 6-alkylangelicinen und von deren salzen
PT81443B (de) Verfahren zur herstellung von corticosteroid-21-phosphorsaeuren und deren salzen und die corticosteroid-21-phosphorsaeuretriester
ATA238481A (de) Verfahren zur herstellung von neuen acylaminophenylpyridinderivaten und deren salzen
ATA238683A (de) Verfahren zur herstellung von neuen eburnan-oxim-aether-derivaten und von deren saeureadditionssalzen
AT375355B (de) Verfahren zur herstellung von neuen phenthiazin-derivaten und von deren salzen
AT382615B (de) Verfahren zur herstellung von neuen substituierten thiamorpholinonderivaten und deren sulfoxiden
ATA154183A (de) Verfahren zur herstellung von neuen imidazochinoxalinen und von deren salzen
AT354440B (de) Verfahren zur herstellung von neuen thiazolidinderivaten und von deren saeure- additionssalzen
AT366665B (de) Verfahren zur herstellung von neuen n-isothioureido-phthalimiden und deren salzen
AT376438B (de) Verfahren zur herstellung von neuen indolizinderivaten und von deren pharmazeutisch zulaessigen saeureadditionssalzen
ATA311479A (de) Verfahren zur herstellung von neuen 4-thiazolidin-carbonsaeurederivaten und von deren salzen und stereoisomeren
ATA90386A (de) Verfahren zur herstellung von neuen substituierten thiamorpholinonderivaten und deren sulfoxiden
ATE21888T1 (de) Verfahren zur herstellung von 2-nitro-5-phenoxy- substituierten-benzoesaeuren und deren salzen.
ATA550680A (de) Verfahren zur herstellung von neuen thienothiazin-derivaten und von deren salzen

Legal Events

Date Code Title Description
A1Z Withdrawn